why choose us

First received: October 20, 2022

Clinical Trial: Channa Striatus Extract on Albumin and Hs-CRP ESRD

Study Status: Completed

Recruit Status: Completed

Condition: End-Stage Renal Disease
Inflammation

Study Type: Interventional


Official Title: The Effect of Channa Striatus Extract on Serum Albumin and High Sensitive C-Reactive Protein in End-Stage Renal Disease Patients

Brief Summary: This study is a randomised, double blind, placebo-controlled study in patients with ESRD on HD or CAPD based RRTs at Moewardi General Hospital in Surakarta, Indonesia from January to March 2021. Subjects were randomized to either a Channa striata or a placebo group and were given a three times daily dosage of 500 mg of Channa striatus extract or 500 mg maltodextrin, respectively for 21 days. Serum albumin and hs-CRP were measured at the baseline, and at the end of the study

Read more